Sengenics Sdn Bhd is a biotechnology company based in Malaysia that focuses on advancing precision medicine and immunology through cutting-edge technology and research. We specialize in developing innovative diagnostic tools and services designed to enhance personalized healthcare, early disease detection, and therapy optimization. Our expertise in biomarker discovery and analysis allows us to deliver highly accurate and tailored solutions for patients and healthcare providers.
We collaborate with global research institutions, pharmaceutical companies, and healthcare professionals to push the boundaries of medical science and improve clinical outcomes. Sengenics is committed to advancing the future of healthcare by providing services that support drug discovery, patient care, and clinical trials. By combining our research-driven approach with state-of-the-art technology, we strive to make a meaningful impact on healthcare innovation and improve the quality of life for patients worldwide.